Posters

Evaluation of the outcome of anterior chamber intraocular lens implantation (Kelman Multiflex) in cases of non-traumatic subluxated lenses in paediatric age group

Poster Details

First Author: N.Yadav INDIA

Co Author(s):    S. Khokhar   T. Agarwal                 

Abstract Details

Purpose:

To evaluate the refractive outcome and corneal endothelial status after anterior chamber(Kelman Multiflex) intraocular lens implantation in cases of non traumatic subluxated lenses in 5 to 15 years age group.

Setting:

Dr. R.P Centre for Ophthalmic Science, A.I.I.M.S, New Delhi.

Methods:

50 eyes of 25 patients with severely subluxated crystalline lenses were recruited in the study. All eyes underwent a standard intralenticular lens aspiration with anterior vitrectomy and placement of anterior chamber intraocular lens implantation (kelman multiflex).Visual acuity and non-contact endothelial cell microscopy was done preoperatively, and at 1week, 1 month, 3 months,6 months, 9 months and 12 months postoperatively.

Results:

The mean best corrected visual acuity (BCVA) significantly improved from 0.73±0.326 log MAR units preoperatively to 0.466±0.017 log MAR units at 1 year (P=0.001) postoperatively.The mean endothelial cell density reduced post operatively at 12 months to 3342.14±431.519 mm2 from the preoperative value of 3782.46±507.458mm2 .The mean number of hexagonal cells was 65.7±6.7 % and the coefficient of variation was 0.322±0.048 at 12 months which was not significant. The percentage decline in endothelial cell density at 1 year was 11.2%.

Conclusions:

The endothelial cell density reduced following surgery where the maximum rate of endothelial cell loss occurred in the first week and 1 month. The rate of cell loss stabilized at 3 months with negligible further cell loss at 12 months. The implantation of anterior chamber intraocular lens (Kelman Multiflex) can be considered as a safe and effective method for correction of aphakia after intralenticular lens aspiration of subluxated lenses in paediatric age group (5 years to 15 years).

Financial Disclosure:

None